Notice2021-12756
Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially Exclusive Patent License
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 17, 2021
Issuing agencies
National Aeronautics and Space Administration
Abstract
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 115 (Thursday, June 17, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Notices]
[Pages 32284-32285]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-12756]
=======================================================================
-----------------------------------------------------------------------
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice: (21-035)]
Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially
Exclusive Patent License
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of intent to grant exclusive, co-exclusive or partially
exclusive patent license.
-----------------------------------------------------------------------
SUMMARY: NASA hereby gives notice of its intent to grant an exclusive,
co-exclusive or partially exclusive patent license to practice the
inventions described and claimed in the patents and/or patent
applications listed in SUPPLEMENTARY INFORMATION below.
DATES: The prospective exclusive, co-exclusive or partially exclusive
license may be granted unless NASA receives written objections
including evidence and argument, no later than July 2, 2021 that
establish that the grant of the license would not be consistent with
the requirements regarding the licensing of federally owned inventions
as set forth in the Bayh-Dole Act and implementing regulations.
Competing applications completed and received by NASA no later than
July 2, 2021 will also be treated as objections to the grant of the
contemplated exclusive, co-exclusive or
[[Page 32285]]
partially exclusive license. Objections submitted in response to this
notice will not be made available to the public for inspection and, to
the extent permitted by law, will not be released under the Freedom of
Information Act.
FOR FURTHER INFORMATION CONTACT: Written objections relating to the
prospective license or requests for further information may be
submitted to Agency Counsel for Intellectual Property, NASA
Headquarters at Email: <a href="/cdn-cgi/l/email-protection#036b722e736277666d776c65656a6066436e626a6f2d6d6270622d646c75"><span class="__cf_email__" data-cfemail="375f461a4756435259435851515e5452775a565e5b195956445619505841">[email protected]</span></a>. Questions may be
directed to Helen Galus at (202) 358-3437.
SUPPLEMENTARY INFORMATION: NASA intends to grant an exclusive, co-
exclusive, or partially exclusive patent license in the United States
to practice the inventions described and claimed in: US 8,735,116 B2,
High-Density Spot Seeding for Tissue Model Formation and US 9,243,223
B2, High-Density Spot Seeding for Tissue Model Formation to BSK Health
Partners, LLC. having its principal place of business in North Richland
Hills, Texas. The fields of use may be limited. NASA has not yet made a
final determination to grant the requested license and may deny the
requested license even if no objections are submitted within the
comment period.
This notice of intent to grant an exclusive, co-exclusive or
partially exclusive patent license is issued in accordance with 35
U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in these
inventions have been assigned to the United States of America as
represented by the Administrator of the National Aeronautics and Space
Administration. The prospective license will comply with the
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Information about other NASA inventions available for licensing can
be found online at <a href="http://technology.nasa.gov">http://technology.nasa.gov</a>.
Helen M. Galus,
Agency Counsel for Intellectual Property.
[FR Doc. 2021-12756 Filed 6-16-21; 8:45 am]
BILLING CODE 7510-13-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 17, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.